Company Filing History:
Years Active: 2010
Title: Sylvie C Meyer Reigner: Innovator in CB2 Receptor Modulation
Introduction
Sylvie C Meyer Reigner is a notable inventor based in Village-Neuf, France. She has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate CB2 receptors. Her work is essential for advancing treatments for various diseases associated with these receptors.
Latest Patents
One of her key patents is titled "Pyrazine-2-carboxamide derivatives as CB2 receptor modulators." This invention relates to compounds of a specific formula, wherein R to R are defined in the description and claims, along with their pharmaceutically acceptable salts. These compounds are particularly useful for the treatment and/or prophylaxis of diseases linked to the modulation of CB2 receptors.
Career Highlights
Throughout her career, Sylvie has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to contribute to significant advancements in drug development.
Collaborations
Sylvie has collaborated with esteemed colleagues such as Michel Dietz and Sabine Gruener. These partnerships have fostered innovation and have been instrumental in her research endeavors.
Conclusion
Sylvie C Meyer Reigner's work in the field of CB2 receptor modulation exemplifies her dedication to advancing medical science. Her innovative patents and collaborations highlight her impact on the pharmaceutical industry.